US2021254145A1PendingUtilityA1
Methods for Attaching Cellular Constituents to a Matrix
Est. expiryApr 22, 2036(~9.7 yrs left)· nominal 20-yr term from priority
C12P 19/34C12Q 1/6841C12Q 1/68C12Q 2523/101C08G 63/91
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method of covalently attaching a chromosome within a cell to a matrix including modifying a plurality of nucleotides within the chromosome to include a matrix attachment moiety wherein the chromosome contacts the matrix, and attaching the matrix attachment moiety of the plurality of nucleotides to the matrix, thereby attaching the chromosome to the matrix.
Claims
exact text as granted — not AI-modified1 - 41 . (canceled)
42 . A method of modeling structure of a chromosome in a cell comprising:
(a) hybridizing to the chromosome a plurality of oligonucleotides,
wherein each oligonucleotide comprises
(1) a hybridization region complementary to a sequence on the chromosome; and
(2) at least one region that is not complementary to the sequence on the chromosome;
(b) contacting the chromosome and the plurality of oligonucleotides hybridized thereto with a matrix-forming material; (c) attaching the plurality of oligonucleotides to the matrix; wherein the plurality of oligonucleotides attached to the matrix represents the structure of the chromosome in the cell;
(d) treating the matrix with a protease and/or passivating the matrix; and;
(e) detecting the modeled chromosome structure.
43 . The method of claim 42 , wherein each of the plurality of oligonucleotides comprise one or more detectable labels, and wherein the step of detecting the modeled chromosome structure comprises detecting the detectable label.
44 . The method of claim 43 , wherein the detectable label comprises a fluorescent label, and wherein the step of detecting the detectable label comprises one or more of fluorescence microscopy, super-resolution microscopy, Stimulated Emission Depletion Microscopy (STED), structured Illumination Microscopy (SIM), and single-molecule super-resolution microscopy technologies selected from Photo-Activated Localization Microscopy (PALM), stochastic Optical Reconstruction Microscopy (STORM) and DNA-based Point Accumulation In Nanoscale Topography (DNA-PAINT).
45 . The method of claim 43 , wherein prior to said detecting the detectable label, the matrix is expanded.
46 . The method of claim 42 , wherein the step of detecting the modeled chromosome structure comprises hybridizing a secondary oligonucleotide comprising a detectable label to at least one of the non-complementary regions of each of the plurality of oligonucleotides, and detecting the detectable label.
47 . The method of claim 46 , wherein the detectable label comprises a fluorescent label, and the step of detecting the detectable label comprises one or more of fluorescence microscopy, super-resolution microscopy, Stimulated Emission Depletion Microscopy (STED), structured Illumination Microscopy (SIM), and single-molecule super-resolution microscopy technologies selected from Photo-Activated Localization Microscopy (PALM), stochastic Optical Reconstruction Microscopy (STORM) and DNA-based Point Accumulation In Nanoscale Topography (DNA-PAINT).
48 . The method of claim 46 , wherein prior to the step of detecting the detectable label, the matrix is expanded.
49 . The method of claim 42 , wherein the step of detecting the modeled chromosome structure comprises amplification of at least a portion of each oligonucleotide of the plurality of oligonucleotides to produce an amplified product, wherein the amplified product comprises one or more detectable labels; and detecting the detectable label.
50 . The method of claim 49 , wherein the amplification comprises rolling circle amplification.
51 . The method of claim 49 , wherein the detectable label comprises a fluorescent label, and the step of detecting the detectable label comprises one or more of fluorescence microscopy, super-resolution microscopy, Stimulated Emission Depletion Microscopy (STED), structured Illumination Microscopy (SIM), and single-molecule super-resolution microscopy technologies selected from Photo-Activated Localization Microscopy (PALM), stochastic Optical Reconstruction Microscopy (STORM) and DNA-based Point Accumulation In Nanoscale Topography (DNA-PAINT).
52 . The method of claim 49 , wherein prior to the step of detecting the detectable label, the matrix is expanded.
53 . The method of claim 42 , wherein the step of detecting the modeled chromosome structure comprises sequencing at least a portion of each oligonucleotide of the plurality of oligonucleotides, wherein sequencing comprises the use of one or more nucleotides comprising a detectable label, and detecting the detectable label.
54 . The method of claim 53 , wherein the detectable label comprises a fluorescent label, and the step of detecting the detectable label comprises one or more of fluorescence microscopy, super-resolution microscopy, Stimulated Emission Depletion Microscopy (STED), structured Illumination Microscopy (SIM), and single-molecule super-resolution microscopy technologies selected from Photo-Activated Localization Microscopy (PALM), stochastic Optical Reconstruction Microscopy (STORM) and DNA-based Point Accumulation In Nanoscale Topography (DNA-PAINT).
55 . The method of claim 53 , wherein prior to the step of detecting the detectable label, the matrix is expanded.
56 . The method of claim 42 , wherein the matrix is expanded and additional oligonucleotides are hybridized to the chromosome and attached to the matrix.
57 . The method of claim 42 , wherein the matrix is repeatedly expanded and additional oligonucleotides are hybridized to the chromosome and attached to the matrix.
58 . The method of claim 42 , wherein each of the plurality of oligonucleotides is directly attached to the matrix.
59 . The method of claim 42 , wherein each of the plurality of oligonucleotides is indirectly attached to the matrix.
60 . The method of claim 42 , wherein each of the plurality of oligonucleotides comprises a second non-complementary region, the method comprising amplifying and/or sequencing at least a portion of the second non-complementary region.
61 . The method of claim 60 , wherein amplification or sequencing comprises the use of a nucleotide comprising a detectable label.Join the waitlist — get patent alerts
Track US2021254145A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.